The invention is related to boronate compds. of formula I with neuroprotective, antiplatelet, antitumor, and antimicrobial activities for the treatment of diseases and conditions assocd. to oxidative stress. Compds. of formula I wherein X1 and X2 are independently CH and CH2; X3 and X4 are independently S and SH; A is (CH2)​n; n is 1 to 10; R is H, (un)​substituted alkyl, (un)​substituted aryl, etc.; R1 and R2 are independently H, CH3, alkyl, etc.; R1 and R2 can be taken together to in a cyclic compd.; and their pharmaceutically acceptable stereoisomers, enantiomers, conformers and racemic mixt. of different stereoisomers thereof, are claimed. Example compd. II was prepd. by amidation of 5-​(S)​-​(1,​2-​dithiolanyl-​3-​yl)​pentanoic acid with 3a,​5,​5-​trimethylhexahydro-​4,​6-​methanobenzo[d]​[1,​3,​2]​dioxaborol-​2-​ylmethylamine hydrochloride. The compds. of formula I were evaluated for their antiplatelet activity (data given)​.

Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress

DI STEFANO ANTONIO;CACCIATORE IVANA;
2018-01-01

Abstract

The invention is related to boronate compds. of formula I with neuroprotective, antiplatelet, antitumor, and antimicrobial activities for the treatment of diseases and conditions assocd. to oxidative stress. Compds. of formula I wherein X1 and X2 are independently CH and CH2; X3 and X4 are independently S and SH; A is (CH2)​n; n is 1 to 10; R is H, (un)​substituted alkyl, (un)​substituted aryl, etc.; R1 and R2 are independently H, CH3, alkyl, etc.; R1 and R2 can be taken together to in a cyclic compd.; and their pharmaceutically acceptable stereoisomers, enantiomers, conformers and racemic mixt. of different stereoisomers thereof, are claimed. Example compd. II was prepd. by amidation of 5-​(S)​-​(1,​2-​dithiolanyl-​3-​yl)​pentanoic acid with 3a,​5,​5-​trimethylhexahydro-​4,​6-​methanobenzo[d]​[1,​3,​2]​dioxaborol-​2-​ylmethylamine hydrochloride. The compds. of formula I were evaluated for their antiplatelet activity (data given)​.
2018
File in questo prodotto:
File Dimensione Formato  
EU_PATENT_2019.pdf

Solo gestori archivio

Tipologia: PDF editoriale
Dimensione 1.15 MB
Formato Adobe PDF
1.15 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/704879
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact